» Articles » PMID: 35913612

Pelvic Floor Dysfunctions in Women with Systemic Lupus Erythematosus: A Cross-sectional Study

Overview
Publisher Springer
Date 2022 Aug 1
PMID 35913612
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction And Hypothesis: As a result of the impairment of the musculoskeletal system, the pelvic floor muscles are likely compromised in women with systemic lupus erythematosus (SLE). We hypothesized that women with SLE would report more symptoms of pelvic floor dysfunction (PFD) and there will be an association between SLE and PFD.

Methods: An online cross-sectional survey was conducted. Data were collected on demographic and anthropometric characteristics, PFD (urinary incontinence, nocturia, anal incontinence, genital-pelvic pain/penetration disorder and pelvic organ prolapse) and obstetric history using a web-based questionnaire. The groups were compared using the Mann-Whitney test for quantitative variables and the chi-squared test for categorical variables. The association between SLE and PFD was tested using logistic regression analysis.

Results: A total of 196 women answered the questionnaire (102 with SLE and 94 healthy controls). Women with SLE reported significantly more urinary incontinence, nocturia, anal incontinence, pelvic organ prolapse and genital-pelvic pain/penetration disorder than the healthy controls (p ≤ 0.05). Women with SLE were 2.8- to 3.0-fold more likely to report genital-pelvic pain/penetration disorder than healthy women.

Conclusions: The prevalence of PFD was significantly higher in women with SLE compared to healthy women. Thus, PFD seems to be an important problem in women with this disease. An in-depth investigation of these disorders could contribute to the understanding of how SLE impacts pelvic floor function.

Citing Articles

Pelvic Floor Dysfunction and Associated Factors in Women with Systemic Autoimmune Rheumatic Diseases: A Cross-Sectional Study.

Carvalho C, Rocha A, Dos Santos G, Guimaraes J, Amorim M, Beleza A Int Urogynecol J. 2025; .

PMID: 39903236 DOI: 10.1007/s00192-025-06071-8.

References
1.
Carter E, Barr S, Clarke A . The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol. 2016; 12(10):605-20. DOI: 10.1038/nrrheum.2016.137. View

2.
Fava A, Petri M . Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2018; 96:1-13. PMC: 6310637. DOI: 10.1016/j.jaut.2018.11.001. View

3.
Messelink B, Benson T, Berghmans B, Bo K, Corcos J, Fowler C . Standardization of terminology of pelvic floor muscle function and dysfunction: report from the pelvic floor clinical assessment group of the International Continence Society. Neurourol Urodyn. 2005; 24(4):374-80. DOI: 10.1002/nau.20144. View

4.
Sung V, Hampton B . Epidemiology of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 2009; 36(3):421-43. DOI: 10.1016/j.ogc.2009.08.002. View

5.
Duran-Barragan S, Ruvalcaba-Naranjo H, Rodriguez-Gutierrez L, Solano-Moreno H, Hernandez-Rios G, Sanchez-Ortiz A . Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus. Lupus. 2008; 17(12):1117-21. DOI: 10.1177/0961203308093458. View